Alzheimer's Disease, Dementia
Conditions
Keywords
Acupuncture, Behavioral and Psychological Symptoms of Dementia, BPSD, MMSE, BEHAVE-AD, The Questionnaire of Acupuncture Events, healthy volunteers
Brief summary
The purpose of the study is to evaluate the safety and tolerability of acupuncture for patients with BPSD & healthy volunteers.
Detailed description
This open label study is designed to evaluate the safety and tolerability of acupuncture as a intervention for patients with Behavioral and Psychological Symptoms of Dementia (BPSD)& healthy volunteers,and this study will enroll a total of 30(15 patients,15healthy volunteers) patients who are suffered from BPSD or healthy volunteers.The patients who have to be suitable for the standard of inclusion criteria will be included,and who have one condition of the exclusion criteria will be excluded,and so do the healthy volunteers.For each enrolled participant will obtain a baseline psychiatric and medical assessment, results of the Mini-Mental Status-Evaluation (MMSE),Behavioral Pathology in Alzheimer's Disease Rating Scale(BEHAVE-AD),Activity of Daily Living Scale(ADL)and other basic information prior to beginning acupuncture.For each participant will get acupuncture which once a day for 7 days running. During the trial the Questionnaire of Acupuncture-related Events have to be evaluated every day, and at the end of the intervention,all of the MMSE,BEHAV-AD,ADL and Treatment Emergent Symptom Scale (TESS)will be investigated.
Interventions
OTHERAcupuncture
Participators will be stimulated at specific acupuncture points as determined for the disease by the professional acupuncturists, and acupuncture once a day,last for one week.
Sponsors
Chengdu University of Traditional Chinese Medicine
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
60 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
The eligibility criteria of the patients arm: Inclusion Criteria: 1. patients who aged 60 to 85(inclusive) years 2. The MMSE score of patients must be between 5 to 26 3. Patients with diagnosis of Alzheimer's Disease according to DSM-Ⅳ（Diagnostic and Statistical Manual of Mental Disorders Fourth Edition) 4. patients have one or more target symptoms of Behavioral and Psychological Symptoms of Dementia(BPSD) on the behavioral psychology in Alzheimer's disease rating scale (BEHAVE-AD),and the target symptoms of BEHAVE-AD have to have occurred nearly daily during the previous week or at least intermittently for 4 weeks 5. Patients (or a legally acceptable representative)have signed the informed consent form
Exclusion criteria
1. Received a diagnosis of a primary psychotic disorder (e.g.schizophrenia，bipolar disorder, severe or recurrent depression),other dementia such as vascular dementia,complex dementia or Lewy-body dementia,or psychosis,agitation, or aggression that could be better accounted for by another medical condition, or substance abuse 2. Had severe system disease (e.g., cardiovascular, hepatorenal, hematopoietic system) or infectious disease 3. Received medication (e.g.,benzodiazepines, antipsychotics, or anticholinergics)which could treat BPSD within 2 weeks prior to the first acupuncture of the study 4. Participated in any clinical trial of drug within 4 weeks prior to the study 5. History of taking acupuncture The eligibility criteria of the healthy volunteers arm: Inclusion Criteria: 1. Healthy volunteers aged 60 to 85(inclusive) years who have provided written informed consent 2. MMSE\> or =27 3. Have relative better health condition who do not suffered from severe system disease (e.g.,cardiovascular, hepatorenal, hematopoietic system) or infectious disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Questionnaire of Acupuncture Events | Every day during a 7 days trial |
Secondary
| Measure | Time frame |
|---|---|
| Change from baseline on Mini-Mental State-Examination（MMSE）,The Behavioral Pathology in Alzheimer's Disease Rating Scale（BEHAVE-AD）and Activity of Daily Living Scale（ADL） | Baseline and 1week after the trial begen |
| Treatment Emergent Symptom Scale (TESS) | Baseline and 2 weeks after the trial begen |
Countries
China
Outcome results
None listed